the Nissi Pharmacies Eve posted losses of R$2.95 million in the third quarter, reducing losses by 78.4% in the year-over-year comparison. The company achieved revenues of R$850 million between July and September, an increase of 11.2% compared to the same period in 2024.
The result before interest, taxes, depreciation and amortization (Ebitda) was R$92.9 million in the third quarter, an increase of 55.2% over the year. In adjusted terms, the index reached R$67 million, i.e. a growth of 65.5%.
“We closed the third quarter with strong results and steady progress on our path toward consolidation and operational consolidation,” Farmácias Nissei said in a statement.
The company indicates that it ended the third quarter with 474 stores distributed in 131 municipalities, which is an expansion compared to 432 stores in the same period in 2024. About 30.5% of pharmacies are in the maturity period.
The company maintained its market leadership parana, 15.2% of pharmacies in the country. in Sao Paulo and Santa Catarina, Nisei’s focus for expansion, reached market shares of 4.11% and 4.16% respectively.
The pharmacy chain’s costs and expenses fell in one year, leading to an increase in margins, with its EBITDA margin rising from 5.03% to 7.4% in the 12-month period, also reflecting its disciplined working capital management.
Nissei’s financial results were negative by R$72 million in the third quarter, affected by the high interest rate environment throughout the period, which put pressure on key financing lines and financial instruments.
The company’s net debt stood at R$688.9 million at the end of September, compared to R$521.7 million last year, but it reduced leverage from 3.56 times to 2.73 times in the period due to better operating performance.
About The Author
